论文部分内容阅读
目的:研究乙型肝炎(Hepatitis Bvirus)患者的临床乙肝五项检验的价值。方法:以2014年6月-2016年6月于我院接受治疗的30例乙肝患者为研究对象,利用酶联免疫吸附法(ELISA)诊断试剂盒检测患者的乙肝五项指标,并统计各指标阳性率。结果:乙肝五项检查结果具有差异性,阳性率最高的指标为HBsAg,其次为抗-HBc和抗-HBs。结论:乙肝五项指标的阳性率虽有一定差异,但各项指标均可作为临床诊断的依据,应加以综合考虑,以保障治疗有效性,提升治愈率。
Objective: To study the clinical value of five hepatitis B tests in patients with Hepatitis B virus. Methods: Thirty patients with hepatitis B treated in our hospital from June 2014 to June 2016 were enrolled in this study. Five indicators of hepatitis B were detected by enzyme linked immunosorbent assay (ELISA) Positive rate. Results: The results of the five tests of hepatitis B were different. The highest positive rate was HBsAg, followed by anti-HBc and anti-HBs. Conclusion: The positive rate of five indicators of hepatitis B although there are some differences, but all the indicators can be used as the basis for clinical diagnosis, should be taken into account to protect the effectiveness of treatment and enhance the cure rate.